Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1990 3
1991 2
1995 1
1997 1
1998 1
2001 1
2002 1
2006 1
2007 3
2008 2
2009 2
2010 4
2014 1
2015 4
2016 4
2017 5
2018 2
2019 6
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey.
Hermanowicz N, Jones SA, Hauser RA. Hermanowicz N, et al. Neuropsychiatr Dis Treat. 2019 Aug 5;15:2205-2212. doi: 10.2147/NDT.S213917. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31496703 Free PMC article.
Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin.
Lyons KE, Pahwa R, Hermanowicz N, Davis T, Pagan F, Isaacson S. Lyons KE, et al. Among authors: hermanowicz n. Expert Rev Clin Pharmacol. 2019 Jul;12(7):681-691. doi: 10.1080/17512433.2019.1623669. Epub 2019 Jun 13. Expert Rev Clin Pharmacol. 2019. PMID: 31159608 Review.
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators. McGarry A, et al. Among authors: hermanowicz n. Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2. Neurology. 2017. PMID: 27913695 Free PMC article. Clinical Trial.
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.
Isaacson SH, Fisher S, Gupta F, Hermanowicz N, Kremens DE, Lew MF, Marek K, Pahwa R, Russell DS, Seibyl J. Isaacson SH, et al. Among authors: hermanowicz n. Expert Rev Neurother. 2017 Mar;17(3):219-225. doi: 10.1080/14737175.2017.1256205. Epub 2016 Nov 23. Expert Rev Neurother. 2017. PMID: 27813429 Review.
Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's disease.
Paff M, Wang AS, Phielipp N, Vadera S, Morenkova A, Hermanowicz N, Hsu FPK. Paff M, et al. Among authors: hermanowicz n. J Robot Surg. 2020 Aug;14(4):559-565. doi: 10.1007/s11701-019-01025-x. Epub 2019 Sep 13. J Robot Surg. 2020. PMID: 31520275
PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson's Disease.
Joshi R, Bronstein JM, Keener A, Alcazar J, Yang DD, Joshi M, Hermanowicz N. Joshi R, et al. Among authors: hermanowicz n. Front Neurol. 2019 Oct 1;10:1027. doi: 10.3389/fneur.2019.01027. eCollection 2019. Front Neurol. 2019. PMID: 31632333 Free PMC article.
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K. Parkinson Study Group QE3 Investigators, et al. Among authors: hermanowicz n. JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131. JAMA Neurol. 2014. PMID: 24664227 Clinical Trial.
The Emerging Role of Pimavanserin in the Management of Parkinson's Disease Psychosis.
Hermanowicz N, Alva G, Pagan F, Espay AJ, Patel A, Madrid KC, Kremens D, Kenney J, Arquette S, Tereso G, Lopes M, Farnum C. Hermanowicz N, et al. J Manag Care Spec Pharm. 2017 Jun;23(6-b Suppl):S2-S8. doi: 10.18553/jmcp.2017.23.6-b.s2. J Manag Care Spec Pharm. 2017. PMID: 28636480 Free article. Review.
Parkinson's disease psychosis: symptoms, management, and economic burden.
Hermanowicz N, Edwards K. Hermanowicz N, et al. Am J Manag Care. 2015 Aug;21(10 Suppl):s199-206. Am J Manag Care. 2015. PMID: 26296199 Free article. Review.
41 results
Jump to page
Feedback